Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT05704595

Effectiveness of Outpatient Intravenous Diuretic Therapy for Treatment of Worsening Heart Failure (OUTPATIENT-WHF)

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Duke University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of the OUTPATIENT-WHF study is to characterize the effectiveness of outpatient intravenous diuretic therapy as a treatment for worsening heart failure.

Detailed description

The purpose of this study is to determine whether treating certain patients with worsening heart failure as an outpatient with intravenous and oral medications can work just as well as treating patients in the hospital. Participants who enter into the study and meet eligibility criteria will be randomly chosen to either get intravenous diuretic like Lasix in the clinic and get outpatient care, versus directly admitted to the hospital to receive intravenous diuretic and normal hospital care.

Conditions

Interventions

TypeNameDescription
OTHERInitial outpatient management strategy, including outpatient IV diuretics in clinicManagement strategy including IV diuretic in the outpatient clinic
OTHERInitial hospitalization-based management strategyDirect admission to the hospital

Timeline

Start date
2023-03-27
Primary completion
2025-04-01
Completion
2025-05-01
First posted
2023-01-30
Last updated
2025-04-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05704595. Inclusion in this directory is not an endorsement.